Melatonin reduced the changes in circadian rhythm, blocked Aβ production, Aβ oligomerization and fibril formation, inhibited tau hyperphosphorylation, and decreased synaptic dysfunction, thus playing a protective role in the progression of AD [255] (Figure 1). The gene discussed is MAPT; the disease is Alzheimer disease.